香川大学医学部薬理学

2006 学会発表等(国際)~Publications(International)~

1
Involvement of Rho-kinase in alsdosterone-induced vascular remodeling.
Nishiyama A. Expert Forum in Total Cardiovascular Risk The Metabolic Syndrome and Obesity, Ontario, Canada, Nov. 2006
2
Involvement of Rho-kinase in alsdosterone-induced vascular remodeling.
Nishiyama A and Miyata K. The 32th International Aldosterone Conference, Boston, MA, Jun. 2006.
3
Enhanced renal interstitial fluid ATP and the tubuloglomerular feedback mechanism in Dahl salt-sensitive hypertensive rats.
Nishiyama A, Rahman M, Kohno M and Navar LG. The 60th Conference of the High Blood Pressure Council, San Antonio, TX, Oct. 2006
4
Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in rat vascular smooth muscle.
Hirofumi H, Hideyasu K, Nishiyama A, Hara T, Kumiko M, Kondo N, Kaifu K, Ihara G, Fujita Y, Kohno M. The 60th Conference of the High Blood Pressure Council, San Antonio, TX, Oct. 2006
5
Role of Rho-kinase in alsdosterone-induced vascular remodeling.
Miyata K, Nagai Y, Kimura S, Kiyomoto H, Hosomi N, Kohno M and Nishiyama A. The 60th Conference of the High Blood Pressure Council, San Antonio, TX, Oct. 2006
6
Effects of aldosterone on insulin receptor substrate-1 expression and insulin signaling in rat vascular smooth muscle cells.
Hitomi H, Kiyomoto H, Nishiyama A, Hara T, Moriwaki K, Kondo N, Kaifu K, Ihara G, Fujita Y and Kohno M. The 32th International Aldosterone Conference, Boston, MA, Jun. 2006.
7
Effects of strict angiotensin blockade with telmisartan on the progression of glomerular injury in type 2 diabetic rats with microalbuminuria. 
Nishiyama A, Nakagawa T, Nagai Y, Miyata K, Okada N, Konishi Y, Morikawa T, Okumura M, Meda I, Kiyomoto H, Hosomi N, Mori T, Ito S and Imanishi M. International Symposium:The Kidney and Hypertension, Sendai, Japan, Oct. 2006
8
Regulation of Intrarenal Angiotensin II formation: Possible role of Chymase.
Nishiyama A. International Symposium: Chymase inhibitors for Cardiovascular Diseases, Fukuoka, Japan, Oct. 2006
9
Renoprotective effects of a chymase inhibitor in type 2 diabetic rats.
Okumura M, Nishiyama A, Nagai Y, Okada N, Morikawa T, Konishi Y, Miyazaki M, Takai S and Imanishi M. International Symposium: Chymase Comprehending Tissue-Angiotensin Generating System, Takarazuka, Japan, Oct. 2006
10
Effects of mineralocorticoid blockade on albumin-induced monocyte chemoattractant activity in human proximal tubular cells.
Nagai Y, Miyata K, Fujisawa Y, Kimura S, Felder RA and Nishiyama A. International Symposium: Chymase Comprehending Tissue-Angiotensin Generating System, Takarazuka, Japan, Oct. 2006
11
Contribution of Rho-kinase to aldosterone-induced vascular remodeling.
Miyata K, Nagai Y, Kimura S, Kiyomoto H, Hosomi N, Kohno M and Nishiyama A. International Symposium: Chymase Comprehending Tissue-Angiotensin Generating System, Takarazuka, Japan, Oct. 2006
12
Role of rat vascular chymase in the progression of renal injury in Dahl salt-sensitive hypertensive rats.
Nishiyama A, Sun G-P, Yao L, Nagai Y, Tamaki K, Miyata K, Ihara G, Kimura S, Kiyomoto H, Kohno M, Miyazaki M and Takai S. International Symposium: Chymase Comprehending Tissue-Angiotensin Generating System, Takarazuka, Japan, Oct. 2006
13
Enhanced renal interstitial fluid ATP and the tubuloglomerular feedback mechanism in Dahl salt-sensitive hypertensive rats.
Rahman M, Kohno M, Navar LG and Nishiyama A. International Symposium: The Kidney and Hypertension, Sendai, Japan, Oct. 2006
14
Potential contributions of Rho-kinase and transforming growth factor-b pathways to aldosterone-induced renal injury. 
Sun G-P, Kohno M, Guo P, Nagai Y, Miyata K, Kimura S and Nishiyama A. International Symposium: The Kidney and Hypertension, Sendai, Japan, Oct. 2006
15
Effects of valsartan on vancomycin-induced renal injury. 
Kondo N, Kiyomoto H, Nagai Y, Fan Y-Y, Hitomi H, Hara T, Moriwaki K, Kimura S, Kohno M and Nishiyama A. International Symposium: The Kidney and Hypertension, Sendai, Japan, Oct. 2006
16
Intrarenal renin-angiotensin system in developing kidneys of type 2 diabetic rats. 
Fan Y-Y, Nagai Y, Kimura S, Abe Y and Nishiyama A. International Symposium: The Kidney and Hypertension, Sendai, Japan, Oct. 2006
17
Insulin attenuates apoptosis induced by high glucose via the phosphatidylinositol 3-kinase-Akt signaling pathway in rat peritoneal mesothelial cells.
Kaifu K, Kiyomoto K, Nishiyama A, Hitomi H, Hara T, Moriwaki K, Kondo N, Ihara G, Fujita Y, Nagata D and Kohno M. International Symposium: The Kidney and Hypertension, Sendai, Japan, Oct. 2006
18
Effect of insulin on apoptosis in rat peritoneal mesothelial cells via the p13-kinase-akt pathway.
Kaifu K, Kiyomoto H, Nishiyama A, Hitomi H, Hara T, Moriwaki K, Kondo K, Ihara G, Fujita Y, Nagata D, Kohno M. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
19
Mechanisms of downregulation of insulin receptor substrate-1 by aldosterone in rat vascular smooth muscle cells. 
Hitomi H, Kiyomoto H, Nishiyama A, Hara T, Moriwaki K, Kondo N, Kaifu K, Ihara G, Fujita Y, Kohno M. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
20
Potential contributions of Rho-kinase and transforming growth factor-b pathways to aldosterone-induced renal injury. 
Sun G-P, Kohno M, Guo P, Nagai Y, Miyata K, Kimura S and Nishiyama A. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
21
Valsartan restores intrarenal nitric oxide synthesis and sodium sensitivity of blood pressure in patients with type 2 diabetic nephropathy. 
Imanishi M, Okada N, Konishi Y, Morikawa T, Maeda I, Okumura M, Masada M and Nishiyama A. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
22
Role of rat vascular chymase in the progression of renal injury in Dahl salt-sensitive hypertensive rats.
Nishiyama A, Sun G-P, Yao L, Nagai Y, Tamaki K, Miyata K, Ihara G, Kimura S, Kiyomoto H, Kohno M, Miyazaki M and Takai S. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
23
Effects of mineralocorticoid receptor blockade on albumin-induced monocyte chemoattractant activity in human proximal tubular cells. 
Nagai Y, Miyata K, Fujisawa Y, Kimura S, Felder RA and Nishiyama A. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
24
Role of Rho-kinase contributes to alsdosterone-induced vascular remodeling.
Miyata K, Nagai Y, Kimura S, Kiyomoto H, Hosomi N, Kohno M and Nishiyama A. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
25
Effects of valsartan on vancomycin-induced renal injury.
Kondo N, Kiyomoto H, Nagai Y, Fan Y-Y, Hitomi H, Hara T, Moriwaki K, Kimura S, Kohno M and Nishiyama A. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
26
Intrarenal renin-angiotensin system in developing kidneys of type 2 diabetic rats.
Fan Y-Y, Nagai Y, Kimura S, Abe Y and Nishiyama A. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
27
Development of renin-angiotensin sysytem-independent nephropathy in diabetic human -prorenin-receptor-transgenic rats.
Kaneshiro Y, Ichihara A, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, Hayashi M, Sizuki F, Inagami T. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
28
10-n-nonyl acridine orange,a cardiolipin specific dye,protects against ischemic-reperfusion injury in rat heaart through inhibition of tbid translocation to mitochondria.
Zhang G, Ohmori K, Nagai Y, Fujisawa Y, Nagai T, Suzuki T, Maeta H, Kohno M, Nishiyama A, kimura S. The 21st Scientific Meeting of the International Society of Hypertension, Fukuoka, Japan, Oct. 2006
29
Effect of insulin on apoptosis in rat peritoneal mesothelial cells via the p13-kinase-akt pathway.
Kaifu K, Kiyomoto K, Nishiyama A, Hitomi H, Hara T, Moriwaki K, Kondo N, Ihara G, Fujita Y, Nagata D, Kohno M. The 21st Scientific Meeting of the International Society of Hypertension , Fukuoka, Japan, Oct. 2006